A Phase I, Open-Label, Single-Sequence Drug-Drug Interaction Trial in Subjects On Stable Methadone Maintenance Therapy, to Investigate the Potential Pharmacokinetic Interaction Between TMC435 and Methadone, at Steady-State
Phase of Trial: Phase I
Latest Information Update: 15 Oct 2013
At a glance
- Drugs Simeprevir (Primary) ; Methadone
- Indications Hepatitis C
- Focus Pharmacokinetics
- Sponsors Janssen R&D Ireland
- 15 Oct 2013 Primary endpoints added as reported by ClinicalTrials.gov.
- 23 Jan 2010 Actual initiation date (Sep 2009) added as reported by ClinicalTrials.gov.
- 23 Jan 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.